Trade

with

Novartis AG
(NYSE: NVS)
AdChoices
90.09
+0.87
+0.98%
After Hours :
-
-
-

Open

89.81

Previous Close

89.22

Volume (Avg)

324.27k (1.35M)

Day's Range

89.69-90.27

52Wk Range

76.36-95.50

Market Cap.

216.51B

Dividend Rate (Yield )

2.72 (3.08%)

Beta

0.56

Shares Outstanding

2.43B

P/E Ratio (EPS)

23.70 (3.94)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 58.83B

    • Net Income

    • 9.18B

    • Market Cap.

    • 216.51B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 16.36

    • PEG (Price/Earnings Growth) Ratio

    • 2.66

    • Beta

    • 0.56

    • Forward P/E

    • 14.90

    • Price/Sales

    • 3.71

    • Price/Book Value

    • 3.08

    • Price/Cash flow

    • 16.13

      • EBITDA

      • 11.42B

      • Return on Capital %

      • 7.91

      • Return on Equity %

      • 13.95

      • Return on Assets %

      • 7.91

      • Book Value/Share

      • 29.01

      • Shares Outstanding

      • 2.43B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 2.72 (2/27/2014)

      • Dividend Declaration Date

      • 2/3/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 101.90

        • Credit Rating

        • AA

        • Analysts

        • 4

        • EPS Estimate

        • 4.03

        • Cashflow Estimate

        • 6.63

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 5.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -3.50

          • 7.80

          • Net Income

            Q/Q (last year)

          • 5.40

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 6.68

          • 6.10

          • Net Income

            5-Year Annual Average

          • 2.50

          • 3.73

          • Dividends

            5-Year Annual Average

          • 10.47

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 66.31

            • 69.92

            • Pre-Tax Margin

            • 17.92

            • 21.84

            • Net Profit Margin

            • 16.36

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 69.40

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 20.10

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 17.00

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.18

              • 0.32

              • Current Ratio

              • 1.27

              • 1.92

              • Quick Ratio

              • 0.61

              • 1.31

              • Interest Coverage

              • 17.02

              • 17.64

              • Leverage Ratio

              • 1.79

              • 2.03

              • Book Value/Share

              • 29.01

              • 14.62

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 23.64

                • 22.62

                • P/E Ratio 5-Year High

                • 25.67

                • 193.96

                • P/E Ratio 5-Year Low

                • 11.69

                • 87.26

                • Price/Sales Ratio

                • 3.65

                • 3.79

                • Price/Book Value

                • 3.03

                • 3.78

                • Price/Cash Flow Ratio

                • 16.13

                • 14.31

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 13.95

                    (14.60)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.91

                    (8.30)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 11.54

                    (12.10)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 72.27k

                  • 90.07k

                  • Inventory Turnover

                  • 2.84

                  • 2.46

                  • Asset Turnover

                  • 0.48

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  10.91B
                  Operating Margin
                  18.54
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  16.13
                  Ownership

                  Institutional Ownership

                  10.36%

                  Top 10 Institutions

                  4.97%

                  Mutual Fund Ownership

                  4.55%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dodge & Cox Stock Fund

                  •  

                    21,710,700

                  • -1.03

                  • 0.89

                  • Dodge & Cox International Stock Fund

                  •  

                    16,305,000

                  • 0.00

                  • 0.67

                  • Vanguard PrimeCap Fund

                  •  

                    13,898,565

                  • 0.00

                  • 0.57

                  • Dodge & Cox Balanced Fund

                  •  

                    3,754,900

                  • 0.00

                  • 0.15

                  • Vanguard Capital Opportunity Fund

                  •  

                    3,131,000

                  • 0.00

                  • 0.13

                  • BBH Core Select Fund

                  •  

                    3,063,899

                  • 0.00

                  • 0.13

                  • VA CollegeAmerica American Mutual

                  •  

                    3,014,000

                  • 0.00

                  • 0.12

                  • Parnassus Core Equity Fund

                  •  

                    2,450,000

                  • 0.00

                  • 0.10

                  • Franklin Mutual Global Discovery Fund

                  •  

                    1,997,437

                  • 0.00

                  • 0.08

                  • Vanguard PrimeCap Core Fund

                  •  

                    1,740,305

                  • 0.00

                  • 0.07

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dodge & Cox

                  •  

                    51,102,219

                  • +10.04%

                  • 2.11

                  • PRIMECAP Management Company

                  •  

                    23,846,236

                  • -0.70%

                  • 0.98

                  • Brown Brothers Harriman & Co

                  •  

                    11,394,385

                  • -8.01%

                  • 0.47

                  • BB&T SECURITIES, LLC

                  •  

                    6,681,220

                  • +877.54%

                  • 0.28

                  • Fisher Asset Management, LLC

                  •  

                    6,015,233

                  • +0.76%

                  • 0.25

                  • Wells Fargo Advisors, LLC

                  •  

                    5,709,169

                  • +2.71%

                  • 0.24

                  • UBS Financial Services Inc.

                  •  

                    4,341,890

                  • +5.16%

                  • 0.18

                  • Northern Trust Investments, N.A.

                  •  

                    4,034,921

                  • +24.75%

                  • 0.17

                  • Managed Account Advisors LLC

                  •  

                    3,960,272

                  • +6.10%

                  • 0.16

                  • Loomis Sayles & Company L.P.

                  •  

                    3,062,631

                  • +6.48%

                  • 0.13

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Classic Growth

                  Style

                  Large Core

                  Novartis AG was incorporated on February 29, 1996 under the laws of Switzerland. On December 20, 1996, our predecessor companies, Ciba-Geigy AG and Sandoz AG, merged into this new entity, creating Novartis. The Company is engaged in ...morethe research, development, manufacturing and marketing of healthcare and pharmaceuticals products. The Company's portfolio includes innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company's wholly-owned businesses are organized into six global operating divisions, and they report teir results in the following five segments: Pharmaceuticals: Innovative patent-protected prescription medicines, Alcon: Surgical, ophthalmic pharmaceutical and vision care products, S...moreandoz: Generic pharmaceuticals, Vaccines and Diagnostics: Preventive human vaccines and blood testing diagnostics, Consumer Health: OTC (over-the-counter medicines) and Animal Health. The Pharmaceuticals dividon researches, develops, manufactures, distributes and sells patented prescription medicines and is organized in the following business franchises: Primary Care, consisting of Primary Care medicines and Established Medicines; and Specialty Care, consisting of Ophthalmology, Neuroscience, Integrated Hospital Care, and Critical Care medicines. The manufacture of the products is complex and heavily regulated by governmental health authorities, which means that supply is never guaranteed. If the or their third party suppliers fail to comply with applicable regulations then there could be a product recall or other shutdown or disruption of our production activities. The Company is subject to the laws of Switzerland, in particular Swiss company and securities laws, and to the securities laws of the United States as applicable to foreign private issuers of securities.lessless

                  Key People

                  Joseph Jimenez

                  CEO

                  Joerg Reinhardt,PhD

                  Chairman of the Board /Director

                  Mr. Harry Kirsch

                  CFO

                  Ms. Ann M. Fudge

                  Director

                  Dr. William R. Brody,M.D.

                  Director

                  • Novartis AG

                  • Lichtstrasse 35

                  • Basel, 4056

                  • CHE.Map

                  • Phone: +41 613241111

                  • Fax: +41 613248001

                  • novartis.com

                  Incorporated

                  1996

                  Employees

                  135,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: